$KREF Balance Sheet | Understand Stock

$KREF

$5.82 +$0.06 (1.04%) Close

$KREF Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Cash and cash equivalents
Commercial real estate loans, held-for-investment
Consolidated Entity, Excluding VIE
Total commercial real estate loans, held-for-investment
Less: Allowance for credit losses
Consolidated Entity, Excluding VIE
Total less: Allowance for credit losses
Commercial real estate loans, held-for-investment, net
Consolidated Entity, Excluding VIE
Primary beneficiary
Total commercial real estate loans, held-for-investment, net
Commercial real estate loan, held-for-sale
Real estate owned, held-for-investment, net
Real estate owned assets, held-for-sale
Equity method investments
Real Estate Asset
CMBS B-Pieces
Unconsolidated Enity
Total equity method investments
Accrued interest receivable
Consolidated Entity, Excluding VIE
Primary beneficiary
Total accrued interest receivable
Investments in CMBS securities
Consolidated variable interest entities assets, CMBS trusts, at fair value
Primary beneficiary
Total consolidated variable interest entities assets, CMBS trusts, at fair value
Real estate owned, held for investment, net
Other assets
Primary beneficiary
Total Assets
Liabilities and Equity
Liabilities
Secured financing agreements, net
Collateralized loan obligations, net
Primary beneficiary
Total collateralized loan obligations, net
Secured term loan, net
Convertible notes, net
Loan participations sold, net
Dividends payable
Accrued interest payable
Consolidated Entity, Excluding VIE
Primary beneficiary
Total accrued interest payable
Accounts payable, accrued expenses and other liabilities
Real estate owned liabilities, held-for-sale
Consolidated variable interest entities liabilities, CMBS trusts, at fair value
Other liabilities
Related party
Nonrelated party
Total other liabilities

Due to affiliates
Primary beneficiary
Total Liabilities

Commitments and Contingencies (Note 15)
Redeemable preferred stock
Equity
Preferred stock, value issued
Voting Preferred Stock
6.5% Series A Cumulative Redeemable Preferred Stock
Preferred Stock, $0.01 par value, 50,000,000 shares authorized Series A cumulative redeemable preferred stock, (13,110,000 shares issued and outstanding as of June 30, 2026 and December 31, 2025); liquidation preference of $327,750, or $25.00 per share
Common stock, $0.01 par value, 300,000,000 authorized (60,929,760 shares issued and 58,577,948 outstanding as of June 30, 2026; 65,488,680 shares issued and 64,367,737 shares outstanding as of December 31, 2025)
Additional paid-in capital
Accumulated deficit
Repurchased stock (5,985,696 and 3,900,326 shares repurchased as of December 31, 2022 and 2021, respectively)
Repurchased stock (2,351,812 and 1,120,943 shares repurchased as of June 30, 2026 and December 31, 2025, respectively)
Total KKR Real Estate Finance Trust Inc. Stockholders’ Equity
Noncontrolling interests in equity of consolidated joint ventures
Total Equity

Total Liabilities and Equity

Common Stock, Shares, Issued
Common stock outstanding (in shares)

Comments